Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 0
  • Market Cap: £116.85m
  • RiskGrade: 262

Cello Group acquires Line Digital

Date: Friday 25 Apr 2014

LONDON (ShareCast) - Marketing firm Cello Group announced it has acquired web design company Line Digital in order to reinforce its digital capability.

The Edinburgh-based agency, which specialises in online marketing, provides for clients such as Standard Life, Tesco Bank, Travel Corp and Edinburgh Fringe. The group has not released any costs related to the acquisition.

The group’s subsidiary Cello Signal, which recently acquired digital agency Blonde, will soon be fully integrated with Line to form Blonde Digital, which it expects to add to its growing knowledge in building digital technology platforms for clients.

Cello also acquired pharmaceutical group, Mash Health, towards the start of the year for a total consideration of £0.6m, which is now part of the firm’s healthcare division.

Managing Director Ross Laurie said: "Integration with Blonde will deliver more support for our clients and staff, more financial stability for growth, and a deeper pool of knowledge for us to draw on. It is an exciting opportunity to expand more aggressively"

As of 08:31, the share price had risen by 0.58% to 85p.

WS

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 101.00
Volume 0
Shares Issued 106.23m
Market Cap £116.85m
RiskGrade 262

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.67% below the market average66.67% below the market average66.67% below the market average66.67% below the market average66.67% below the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average
Price Trend
28.86% above the market average28.86% above the market average28.86% above the market average28.86% above the market average28.86% above the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Income
13.13% below the market average13.13% below the market average13.13% below the market average13.13% below the market average13.13% below the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average
Growth
39.87% below the market average39.87% below the market average39.87% below the market average39.87% below the market average39.87% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

Cello Health Key Personnel

CEO Mark Scott

Top of Page